Mechanisms Pertaining to Arsenic Toxicity

Jump To References Section


  • Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar - 143 005 ,IN
  • Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala - 147 002 ,IN
  • Department of Pharmacology, Khalsa College of Pharmacy, Amritsar - 143 005 ,IN


Arsenic, carcinogenicity, cardiovascular dysfunction, diabetes, hepatotoxicity, nephrotoxicity, neurotoxicity


Arsenic is an environmental pollutant and its contamination in the drinking water is considered as a serious worldwide environmental health threat. The chronic arsenic exposure is a cause of immense health distress as it accounts for the increased risk of various disorders such as cardiovascular abnormalities, diabetes mellitus, neurotoxicity, and nephrotoxicity. In addition, the exposure to arsenic has been suggested to affect the liver function and to induce hepatotoxicity. Moreover, few studies demonstrated the induction of carcinogenicity especially cancer of the skin, bladder, and lungs after the chronic exposure to arsenic. The present review addresses diverse mechanisms involved in the pathogenesis of arsenic-induced toxicity and end-organ damage.


Download data is not yet available.



How to Cite

Singh, A. P., Goel, R. K., & Kaur, T. (2018). Mechanisms Pertaining to Arsenic Toxicity. Toxicology International, 18(2), 87–93. Retrieved from



Review Articles
Received 2018-05-17
Accepted 2018-05-17
Published 2018-05-18



WHO (World Health Organization). Fact sheet no. 210. Geneva: WHO; 1999.

Steinmaus C, Carrigan K, Kalman D, Atallah R, Yuan Y, Smith AH. Dietary intake and arsenic methylation in a U.S. population. Environ Health Perspect 2005;113:1153-9.

National Research Council (NRC). Arsenic in drinking water. Washington D C: National Academy Press; 2001.

Kinniburgh DG, Smedley PL. Arsenic contamination of ground water in Bangladesh: Volume 2: Final report. Keyworth, Nottinghamshire: British Geological Survey; 2001.

Alam MG, Allinson G, Stagnitti F, Tanaka A, Westbrooke M. Arsenic contamination in Bangladesh groundwater: a major environmental and social disaster. Int J Environ Health Res 2002;12:235-53.

Chen Y, Parvez F, Gamble M, Islam T, Ahmed A, Argos M, et al. Arsenic exposure at low-to-moderate levels and skin lesions, arsenic metabolism, neurological functions, and biomarkers for respiratory and cardiovascular diseases: review of recent findings from the Health Effects of Arsenic Longitudinal Study (HEALS) in Bangladesh. Toxicol Appl Pharmacol 2009;239:184-92

Tseng CH. An overview on peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Angiology 2002;53:529-37.

Domingo JL. Prevention by chelating agents of metal-induced developmental toxicity. Reprod Toxicol 1995;9:105-13.

Klaassen CD. Heavy metals and heavy metal antagonist. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The Pharmacological Basis of Therapeutics. 9th ed. New York: McGraw Hill; 1996. p. 1592-614.

Ratnaike RN. Acute and chronic arsenic toxicity. Postgraduate Med J 2003;79:391-6.

Lindberg AL, Kumar R, Goessler W, Thirumaran R, Gurzau E, Koppova K, et al. Metabolism of low-dose inorganic arsenic in a central European population: influence of sex and genetic polymorphisms. Environ Health Perspect 2007;115:1081-6.

Hansen ES. International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/2. Shared risk factors for cancer and atherosclerosis-a review of the epidemiological evidence. Mutat Res 1990;239:163-79.

Chen CJ, Hsueh YM, Lai MS, Shyu MP, Chen SY, Wu MM, et al. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995;25:53-60.

Chen CJ, Chiou HY, Chiang MH, Lin LJ, Tai TY. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 1996;16:504-10.

Rahman M, Axelson O. Diabetes mellitus and arsenic exposure: a second look at case-control data from a Swedish copper smelter. Occup Environ Med 1995;52:773-4.

Liu J, Liu Y, Goyer RA, Achanzar W, Waalkes MP. Metallothionein-I/ II null mice are more sensitive than wild-type mice to the hepatotoxic and nephrotoxic effects of chronic oral or injected inorganic arsenicals. Toxicol Sci 2000;55:460-7.

Gurr JR, Yih LH, Samikkannu T, Bau DT, Lin SY, Jan KY. Nitric oxide production by arsenite. Mutat Res 2003;533:173-82.

Ohnishi K, Yoshida H, Shigeno K, Nakamura S, Fujisawa S, Naito K, et al. Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med 2000;133:881-5.

Barchowsky A, Klei LR, Dudek EJ, Swartz HM, James PE. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radic Biol Med 1999;27:1405-12.

Smith KR, Klei LR, Barchowsky A. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol 2001;280:L442-9.

Bunderson M, Coffin JD, Beall HD. Arsenic induces peroxynitrite generation and cyclooxygenase-2 protein expression in aortic endothelial cells: possible role in atherosclerosis. Toxicol Appl Pharmacol 2002;184:11-8.

Lee PC, Ho IC, Lee TC. Oxidative stress mediates sodium arsenite-induced expression of heme oxygenase-1, monocyte chemoattractant protein-1, and interleukin-6 in vascular smooth muscle cells. Toxicol Sci 2005;85:541-50.

Pysher MD, Chen QM, Vaillancourt RR. Arsenic alters vascular smooth muscle cell focal adhesion complexes leading to activation of FAK-src mediated pathways. Toxicol Appl Pharmacol 2008;231:135-41.

Bunderson M, Brooks DM, Walker DL, Rosenfeld ME, Coffin JD, Beall HD. Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol Appl Pharmacol 2004;201:32-9.

Tsai SH, Hsieh MS, Chen L, Liang YC, Lin JK, Lin SY. Suppression of Fas ligand expression on endothelial cells by arsenite through reactive oxygen species. Toxicol Lett 2001;123:11-9.

Chen SC, Tsai MH, Wang HJ, Yu HS, Chang LW. Involvement of substance P and neurogenic inflammation in arsenic-induced early vascular dysfunction. Toxicol Sci 2007;95:82-8.

Pereira FE, Coffin JD, Beall HD. Activation of protein kinase C and disruption of endothelial monolayer integrity by sodium arsenite-Potential mechanism in the development of atherosclerosis. Toxicol Appl Pharmacol 2007;220:164-77.

Tsou TC, Tsai FY, Hsieh YW, Li LA, Yeh SC, Chang LW. Arsenite induces endothelial cytotoxicity by down-regulation of vascular endothelial nitric oxide synthase. Toxicol Appl Pharmacol 2005;208:277-84.

Balakumar P, Kaur J. Arsenic exposure and cardiovascular disorders: an overview. Cardiovasc Toxicol 2009;9:169-76.

Lee MY, Lee YH, Lim KM, Chung SM, Bae ON, Kim H, et al. Inorganic arsenite potentiates vasoconstriction through calcium sensitization in vascular smooth muscle. Environ Health Perspect 2005;113:1330-5.

Cifuentes F, Bravo J, Norambuena M, Stegen S, Ayavire A, Palacios J. Chronic exposure to arsenic in tap water reduces acetylcholine-induced relaxation in the aorta and increases oxidative stress in female rats. Int J Toxicol 2009;28:534-41.

Raghu KG, Yadav GK, Singh R, Prathapan A, Sharma S, Bhadauria S. Evaluation of adverse cardiac effects induced by arsenic trioxide, a potent anti-APL drug. J Environ Pathol Toxicol Oncol 2009;28:241-52.

Jindal S, Singh M, Balakumar P. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arseniteinduced vascular endothelial dysfunction in rats. Int J Cardiol 2008;128:383-91.

Kaur T, Goel RK, Balakumar P. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction. Arch Pharm Res 2010;33:611-8.

Wauson EM, Langan AS, Vorce RL. Sodium arsenite inhibits and reverses expression of adipogenic and fat cell-specific genes during in vitro adipogenesis. Toxicol Sci 2002;65:211-9.

Tseng CH. The potential biological mechanisms of arsenic-induced diabetes mellitus. Toxicol Appl Pharmacol 2004;197:67-83.

Bodwell JE, Kingsley LA, Hamilton JW. Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. Chem Res Toxicol 2004;17:1064-76.

Pal S, Chatterjee AK. Prospective protective role of melatonin against arsenic-induced metabolic toxicity in wistar rats. Toxicology 2005;208:25-33.

Dí­az-Villaseñor A, Sánchez-Soto MC, Cebrián ME, OstroskyWegman P, Hiriart M. Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol Appl Pharmacol 2006;214:30-4.

Izquierdo-Vega JA, Soto CA, Sanchez-Peña LC, De Vizcaya-Ruiz A, Del Razo LM. Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicol Lett 2006;160:135-42.

Paul DS, Harmon AW, Devesa V, Thomas DJ, Stí½blo M. Molecular mechanisms of the diabetogenic effects of arsenic: inhibition of insulin signaling by arsenite and methylarsonous acid. Environ Health Perspect 2007;115:734-42.

Yadav RS, Shukla RK, Sankhwar ML, Patel DK, Ansari RW, Pant AB, et al. Neuroprotective effect of curcumin in arsenic-induced neurotoxicity in rats. Neurotoxicology 2010;31:533-9.

Brinkel J, Khan MH, Kraemer A. A systematic review of arsenic exposure and its social and mental health effects with special reference to Bangladesh. Int J Environ Res Public Health 2009;6:1609-19.

Piao F, Ma N, Hiraku Y, Murata M, Oikawa S, Cheng F, et al. Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J Occup Health 2005;47:445-9.

Felix K, Manna SK, Wise K, Barr J, Ramesh GT. Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells. J Biochem Mol Toxicol 2005;19:67-77.

Yip SF, Yeung YM, Tsui EY. Severe neurotoxicity following arsenic therapy for acute promyelocytic leukemia: potentiation by thiamine deficiency. Blood 2002;99:3481-2.

Gopalkrishnan A, Rao MV. Amelioration by vitamin A upon arsenic induced metabolic and neurotoxic effects. J Health Sci 2006;52:568-77.

Vahidnia A, Romijn F, Tiller M, van der Voet GB, de Wolff FA. Arsenic-induced toxicity: effect on protein composition in sciatic nerve. Hum Exp Toxicol 2006;25:667-74.

Bardullas U, Limón-Pacheco JH, Giordano M, Carrizales L, Mendoza-Trejo MS, Rodrí­guez VM. Chronic low-level arsenic exposure causes gender-specific alterations in locomotor activity, dopaminergic systems, and thioredoxin expression in mice. Toxicol Appl Pharmacol 2009;239:169-77.

Dwivedi N, Flora SJ. Concomitant exposure to arsenic and organophosphates on tissue oxidative stress in rats. Food Chem Toxicol 2011;49:1152-9.

Rodrí­guez VM, Carrizales L, Mendoza MS, Fajardo OR, Giordano M. Effects of sodium arsenite exposure on development and behavior in the rat. Neurotoxicol Teratol 2002;24:743-50.

Namgung U, Xia Z. Arsenic induces apoptosis in rat cerebellar neurons via activation of JNK3 and p38 MAP kinases. Toxicol Appl Pharmacol 2001;174:130-8.

Vahidnia A, Romijn F, van der Voet GB, de Wolff FA. Arsenicinduced neurotoxicity in relation to toxicokinetics: effects on sciatic nerve proteins. Chem Biol Interact 2008;176:188-95.

Patlolla AK, Tchounwou PB. Serum acetyl cholinesterase as a biomarker of arsenic induced neurotoxicity in sprague-dawley rats. Int J Environ Res Public Health 2005;2:80-3.

Luo JH, Qiu ZQ, Shu WQ, Zhang YY, Zhang L, Chen JA. Effects of arsenic exposure from drinking water on spatial memory, ultrastructures and NMDAR gene expression of hippocampus in rats. Toxicol Lett 2009;184:121-5.

Krüger K, Straub H, Hirner AV, Hippler J, Binding N, Musshoff U. Effects of monomethylarsonic and monomethylarsonous acid on evoked synaptic potentials in hippocampal slices of adult and young rats. Toxicol Appl Pharmacol 2009;236:115-23.

Rí­os R, Zarazúa S, Santoyo ME, Sepúlveda-Saavedra J, RomeroDí­az V, Jiménez V, et al. Decreased nitric oxide markers and morphological changes in the brain of arsenic-exposed rats. Toxicology 2009;261:68-75.

Burton CA, Hatlelid K, Divine K, Carter DE, Fernando Q, Brendel K, et al. Glutathione effects on toxicity and uptake of mercuric chloride and sodium arsenite in rabbit renal cortical slices. Environ Health Perspect 1995;103:81-4.

Parrish AR, Zheng XH, Turney KD, Younis HS, Gandolfi AJ. Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slices. Toxicol Sci 1999;50:98-105.

Sasaki A, Oshima Y, Fujimura A. An approach to elucidate potential mechanism of renal toxicity of arsenic trioxide. Exp Hematol 2007;35:252-62.

Kimura A, Ishida Y, Hayashi T, Wada T, Yokoyama H, Sugaya T, et al. Interferon-gamma plays protective roles in sodium arsenite-induced renal injury by up-regulating intrarenal multidrug resistance-associated protein 1 expression. Am J Pathol 2006;169:1118-28.

Saxena PN, Anand S, Saxena N, Bajaj P. Effect of arsenic trioxide on renal functions and its modulation by Curcuma aromatica leaf extract in albino rat. J Environ Biol 2009;30:527-31.

Das AK, Bag S, Sahu R, Dua TK, Sinha MK, Gangopadhyay M, et al. Protective effect of Corchorus olitorius leaves on sodium arsenite-induced toxicity in experimental rats. Food Chem Toxicol 2010;48:326-35.

Nandi D, Patra RC, Swarup D. Oxidative stress indices and plasma biochemical parameters during oral exposure to arsenic in rats. Food Chem Toxicol 2006;44:1579-84.

Kokilavani V, Devi MA, Sivarajan K, Panneerselvam C. Combined efficacies of DL-alpha-lipoic acid and meso 2, 3 dimercaptosuccinic acid against arsenic induced toxicity in antioxidant systems of rats. Toxicol Lett 2005;160:1-7.

Bashir S, Sharma Y, Irshad M, Nag TC, Tiwari M, Kabra M, et al. Arsenic induced apoptosis in rat liver following repeated 60 days exposure. Toxicology 2006;217:63-70.

Suzuki T, Tsukamoto I. Arsenite induces apoptosis in hepatocytes through an enhancement of the activation of Jun N-terminal kinase and p38 mitogen-activated protein kinase caused by partial hepatectomy. Toxicol Lett 2006;165: 257-64.

Jain A, Yadav A, Bozhkov AI, Padalko VI, Flora SJ. Therapeutic efficacy of silymarin and naringenin in reducing arsenicinduced hepatic damage in young rats. Ecotoxicol Environ Saf 2011;74:607-14.

Flora SJ, Mehta A, Gupta R. Prevention of arsenic-induced hepatic apoptosis by concomitant administration of garlic extracts in mice. Chem Biol Interact 2009;177:227-33.

Xu Y, Wang H, Wang Y, Zheng Y, Sun G. Effects of folate on arsenic toxicity in Chang human hepatocytes: Involvement of folate antioxidant properties. Toxicol Lett 2010;195:44-50.

Li GX, Pei QL, Gao Y, Liu KM, Nie JS, Han G, et al. Protective effects of hepatocellular canalicular conjugate export pump (Mrp2) on sodium arsenite-induced hepatic dysfunction in rats. Exp Toxicol Pathol 2007;58:447-53.

Dopp E, Hartmann LM, Florea AM, von Recklinghausen U, Pieper R, Shokouhi B, et al. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells. Toxicol Appl Pharmacol 2004;201:156-65.

Yang C, Frenkel K. Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis. J Environ Pathol Toxicol Oncol 2002;21:331-42.

Liu J, Waalkes M. Focal adhesion kinase as a potential target in arsenic toxicity. Toxicol Sci 2005;84:212-3.

Kinoshita A, Wanibuchi H, Wei M, Yunoki T, Fukushima S. Elevation of 8-hydroxydeoxyguanosine and cell proliferation via generation of oxidative stress by organic arsenicals contributes to their carcinogenicity in the rat liver and bladder. Toxicol Appl Pharmacol 2007;221:295-305.

Suzuki S, Arnold LL, Pennington KL, Kakiuchi-Kiyota S, Cohen SM. Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium. Toxicology 2009;261:41-6.

Simeonova PP, Wang S, Toriuma W, Kommineni V, Matheson J, Unimye N, et al. Arsenic mediates cell proliferation and gene expression in the bladder epithelium: association with activating protein-1 transactivation. Cancer Res 2000;60:3445-53.

Bates MN, Smith AH, Cantor KP. Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 1995;141:523-30.

Hays AM, Srinivasan D, Witten ML, Carter DE, Lantz RC. Arsenic and cigarette smoke synergistically increase DNA oxidation in the lung. Toxicol Pathol 2006;34:396-404.

Klein CB, Leszczynska J, Hickey C, Rossman TG. Further evidence against a direct genotoxic mode of action for arsenic-induced cancer. Toxicol Appl Pharmacol 2007;222:289-97.

Tapio S, Grosche B. Arsenic in the aetiology of cancer. Mutat Res 2006;612:215-46.

Biswas J, Sinha D, Mukherjee S, Roy S, Siddiqi M, Roy M. Curcumin protects DNA damage in a chronically arsenic-exposed population of West Bengal. Hum Exp Toxicol 2010;29:513-24.